
Crowded markets. Complex science. High stakes. To stand out in today’s medical device and MedTech environment, you need more than compelling messaging. Success requires a communications strategy grounded in insight, evidence, and opportunity.
BRG’s Communications Diagnostic delivers a fast, focused evaluation of your communications landscape. In six weeks or less, we assess your narrative, channels, audiences, and competitive environment to identify what’s working, what’s missing, and where your story can break through.
With decades of medical device and MedTech communications expertise, BRG identifies the voices shaping your category and pinpoints where credibility is built – and lost. The result is a clear, prioritized path to stronger awareness, relevance, and trust.
Whether you’re preparing for a product launch, deepening clinician and patient engagement, or strengthening corporate reputation and investor confidence, BRG’s Communications Diagnostic delivers a data-informed blueprint that aligns with business objectives and bottom-line impact.
Whether you’re pre-launch, scaling commercialization, or refining long-term brand positioning, BRG’s Communications Diagnostic gives leadership teams a clear view of how their story is landing — and where focus, refinement, or restraint will matter most.
Ready to unlock your brand’s communications advantage and transform your presence in the market? Fill out the form to start the conversation.

Tasso, an innovative health technology company, is transforming traditional blood collection using a new patient-centric approach that is simple, convenient and virtually painless. Tasso challenged BRG to increase brand awareness and support the company’s continued growth including partnership visibility and FDA milestones. BRG built the ongoing custom program based on insights gained through our trusted Communications Diagnostic approach.
Results:

When Medtronic, a global leader in medical technology, prepared to advance its hypertension technology through critical clinical, regulatory and reimbursement milestones, the company faced a crowded, highly scrutinized category dominated by aggressive competitive claims and patient skepticism.
To ground decisions in data, BRG conducted a comprehensive Communications Diagnostic during key moments – mapping competitive narrative landscape, auditing media and stakeholder perceptions, pressure-testing core messaging and identifying “right to win” areas beyond clinical endpoints.
Results: